Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway

Non-small cell lung cancer (NSCLC), which accounts for more than 80% of lung cancers, is a leading cause of cancer mortality worldwide. However, the mechanism underlying its progression remains unclear. Here we found that HIC1 promoter was heavily methylated in NSCLC cell lines and tissues contribut...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiumin, Wang, Yingying, Xiao, Gang, Wang, Jinglong, Zu, Lidong, Hao, Mingang, Sun, Xueqing, Fu, Yujie, Hu, Guohong, Wang, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058685/
https://www.ncbi.nlm.nih.gov/pubmed/27107418
http://dx.doi.org/10.18632/oncotarget.8734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058685/
https://www.ncbi.nlm.nih.gov/pubmed/27107418
http://dx.doi.org/10.18632/oncotarget.8734

Ejemplares similares